{"id":"https://openalex.org/W4387905775","doi":"https://doi.org/10.1186/s43094-023-00546-5","title":"Method operable design region for robust RP-HPLC analysis of pioglitazone hydrochloride and teneligliptin hydrobromide hydrate: incorporating hybrid principles of white analytical chemistry and design of experiments","display_name":"Method operable design region for robust RP-HPLC analysis of pioglitazone hydrochloride and teneligliptin hydrobromide hydrate: incorporating hybrid principles of white analytical chemistry and design of experiments","publication_year":2023,"publication_date":"2023-10-24","ids":{"openalex":"https://openalex.org/W4387905775","doi":"https://doi.org/10.1186/s43094-023-00546-5"},"language":"en","primary_location":{"id":"doi:10.1186/s43094-023-00546-5","doi":"https://doi.org/10.1186/s43094-023-00546-5","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s43094-023-00546-5","pdf_url":"https://fjps.springeropen.com/counter/pdf/10.1186/s43094-023-00546-5","source":{"id":"https://openalex.org/S2898388368","display_name":"Future Journal of Pharmaceutical Sciences","issn_l":"2314-7245","issn":["2314-7245","2314-7253"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","poland-20","russia-white-list-3"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Future Journal of Pharmaceutical Sciences","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://fjps.springeropen.com/counter/pdf/10.1186/s43094-023-00546-5","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5036437922","display_name":"Pintu Prajapati","orcid":"https://orcid.org/0000-0002-5282-2087","observed_orcids":["https://orcid.org/0000-0002-5282-2087","https://orcid.org/0000-0002-0374-4529"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Pintu Prajapati","raw_affiliation_strings":["Department of Quality Assurance, Maliba Pharmacy College, Maliba Campus, Bardoli-Mahuva Road, Tarsadi, Mahuva, Surat, 394 350, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Quality Assurance, Maliba Pharmacy College, Maliba Campus, Bardoli-Mahuva Road, Tarsadi, Mahuva, Surat, 394 350, India","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114107038","display_name":"Bageshree Rana","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bageshree Rana","raw_affiliation_strings":["Department of Quality Assurance, Maliba Pharmacy College, Maliba Campus, Bardoli-Mahuva Road, Tarsadi, Mahuva, Surat, 394 350, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Quality Assurance, Maliba Pharmacy College, Maliba Campus, Bardoli-Mahuva Road, Tarsadi, Mahuva, Surat, 394 350, India","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028736898","display_name":"Veera Shakar Pulusu","orcid":"https://orcid.org/0000-0003-1801-6388","observed_orcids":["https://orcid.org/0000-0003-1801-6388"]},"institutions":[{"id":"https://openalex.org/I4210106879","display_name":"Ohio University","ror":"https://ror.org/01jr3y717","country_code":"US","type":"education","lineage":["https://openalex.org/I4210106879"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Veera Shakar Pulusu","raw_affiliation_strings":["Department of Chemistry and Biochemistry, Ohio University, Anthens, OH, 45701, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry and Biochemistry, Ohio University, Anthens, OH, 45701, USA","institution_ids":["https://openalex.org/I4210106879"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5064741534","display_name":"Shailesh Amritlal Shah","orcid":"https://orcid.org/0000-0002-1039-9882","observed_orcids":["https://orcid.org/0000-0002-1039-9882","https://orcid.org/0000-0001-6973-6954"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shailesh Shah","raw_affiliation_strings":["Department of Quality Assurance, Maliba Pharmacy College, Maliba Campus, Bardoli-Mahuva Road, Tarsadi, Mahuva, Surat, 394 350, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Quality Assurance, Maliba Pharmacy College, Maliba Campus, Bardoli-Mahuva Road, Tarsadi, Mahuva, Surat, 394 350, India","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5036437922"],"corresponding_institution_ids":[],"apc_list":{"value":0,"currency":"USD","value_usd":0},"apc_paid":null,"fwci":5.5214,"has_fulltext":true,"cited_by_count":57,"citation_normalized_percentile":{"value":0.98235399,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":99,"max":100},"biblio":{"volume":"9","issue":"1","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10908","display_name":"Analytical Chemistry and Chromatography","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10800","display_name":"Forensic Toxicology and Drug Analysis","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pioglitazone-hydrochloride","display_name":"pioglitazone hydrochloride","score":0.9959999918937683},{"id":"https://openalex.org/keywords/rp-hplc-method-development","display_name":"RP-HPLC method development","score":0.8579999804496765},{"id":"https://openalex.org/keywords/white-analytical-chemistry","display_name":"white analytical chemistry","score":0.9070000052452087},{"id":"https://openalex.org/keywords/green-analytical-chemistry","display_name":"green analytical chemistry","score":0.9259999990463257},{"id":"https://openalex.org/keywords/experimental-design","display_name":"experimental design","score":0.6660000085830688},{"id":"https://openalex.org/keywords/response-surface-methodology","display_name":"response surface methodology","score":0.871999979019165},{"id":"https://openalex.org/keywords/fixed-dose-combination","display_name":"fixed-dose combination","score":0.6959999799728394},{"id":"https://openalex.org/keywords/simultaneous-determination","display_name":"simultaneous determination","score":0.5960000157356262},{"id":"https://openalex.org/keywords/methodological-robustness","display_name":"method robustness","score":0.5379999876022339},{"id":"https://openalex.org/keywords/environmentally-friendly-solvents","display_name":"environmentally friendly solvents","score":0.7950000166893005},{"id":"https://openalex.org/keywords/type-2-diabetes-drugs","display_name":"type 2 diabetes drugs","score":0.6489999890327454}],"concepts":[{"id":"https://openalex.org/C2778384471","wikidata":"https://www.wikidata.org/wiki/Q417765","display_name":"Pioglitazone","level":4,"score":0.8071261048316956},{"id":"https://openalex.org/C169222746","wikidata":"https://www.wikidata.org/wiki/Q4116558","display_name":"Factorial experiment","level":2,"score":0.5551146864891052},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.489080011844635},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.44392386078834534},{"id":"https://openalex.org/C179998833","wikidata":"https://www.wikidata.org/wiki/Q381233","display_name":"High-performance liquid chromatography","level":2,"score":0.42834362387657166},{"id":"https://openalex.org/C21880701","wikidata":"https://www.wikidata.org/wiki/Q2144042","display_name":"Process engineering","level":1,"score":0.3214579224586487},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.27394717931747437},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.1493922770023346},{"id":"https://openalex.org/C119857082","wikidata":"https://www.wikidata.org/wiki/Q2539","display_name":"Machine learning","level":1,"score":0.07593998312950134},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.0},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.0},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.0},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1186/s43094-023-00546-5","doi":"https://doi.org/10.1186/s43094-023-00546-5","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s43094-023-00546-5","pdf_url":"https://fjps.springeropen.com/counter/pdf/10.1186/s43094-023-00546-5","source":{"id":"https://openalex.org/S2898388368","display_name":"Future Journal of Pharmaceutical Sciences","issn_l":"2314-7245","issn":["2314-7245","2314-7253"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","poland-20","russia-white-list-3"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Future Journal of Pharmaceutical Sciences","raw_type":"journal-article"},{"id":"pmh:oai:doaj.org/article:fde224ef1b084a7ebedd8ca58d7d536a","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/fde224ef1b084a7ebedd8ca58d7d536a","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Future Journal of Pharmaceutical Sciences, Vol 9, Iss 1, Pp 1-15 (2023)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1186/s43094-023-00546-5","doi":"https://doi.org/10.1186/s43094-023-00546-5","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s43094-023-00546-5","pdf_url":"https://fjps.springeropen.com/counter/pdf/10.1186/s43094-023-00546-5","source":{"id":"https://openalex.org/S2898388368","display_name":"Future Journal of Pharmaceutical Sciences","issn_l":"2314-7245","issn":["2314-7245","2314-7253"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","poland-20","russia-white-list-3"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Future Journal of Pharmaceutical Sciences","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/12","score":0.5171999931335449,"display_name":"Responsible consumption and production"},{"id":"https://metadata.un.org/sdg/3","score":0.504800021648407,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320330154","display_name":"Uka Tarsadia University","ror":"https://ror.org/059xgrv47"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4387905775.pdf","grobid_xml":"https://content.openalex.org/works/W4387905775.grobid-xml"},"referenced_works_count":13,"referenced_works":["https://openalex.org/W1973394411","https://openalex.org/W2408382927","https://openalex.org/W2767086483","https://openalex.org/W3012746514","https://openalex.org/W3023460154","https://openalex.org/W3132104108","https://openalex.org/W3183851070","https://openalex.org/W3204872736","https://openalex.org/W4212977660","https://openalex.org/W4224277899","https://openalex.org/W4286110949","https://openalex.org/W4317212797","https://openalex.org/W4375833945"],"related_works":["https://openalex.org/W4386694141","https://openalex.org/W4317212797","https://openalex.org/W4404766201","https://openalex.org/W4407104275","https://openalex.org/W4385442020","https://openalex.org/W4389482501","https://openalex.org/W7134171007","https://openalex.org/W4292356895","https://openalex.org/W4414612771","https://openalex.org/W4387956676"],"abstract_inverted_index":{"Abstract":[0],"Background":[1],"A":[2,134],"combination":[3],"of":[4,28,30,64,74,82,109,154,163,205,220,246,285],"pioglitazone":[5,115,221],"hydrochloride":[6],"with":[7,177],"teneligliptin":[8,286],"hydrobromide":[9],"hydrate":[10],"is":[11,56],"used":[12,37,91,159,233],"to":[13,49,52,58,78,143,167,235],"treat":[14],"type-2":[15],"diabetes.":[16],"Several":[17],"chromatographic":[18,72,89,124,208],"techniques":[19],"have":[20,96,116],"been":[21,119,128,141],"described":[22],"in":[23,70,130,239],"the":[24,53,62,71,80,86,105,131,155,161,164,174,187,193,203,211,247,282,289],"literature":[25],"for":[26,44,92,202],"determination":[27],"each":[29],"these":[31,35,65,75,237],"medications":[32,77],"separately.":[33],"But":[34],"procedures":[36],"organic":[38,169],"solvents":[39,69],"that":[40,126,173],"could":[41],"be":[42],"dangerous":[43],"humans":[45],"and":[46,67,84,102,114,149,171,192,222,231,249,258,273,287,295],"animals,":[47],"not":[48,117],"mention":[50],"harmful":[51],"environment.":[54,87],"It":[55],"vital":[57],"substitute":[59],"or":[60],"reduce":[61,168],"use":[63],"neurotoxic":[66],"teratogenic":[68],"analysis":[73,94,219,259],"anti-diabetic":[76],"ensure":[79],"safety":[81],"life":[83],"safeguard":[85],"The":[88,152,225],"technique":[90,228],"sample":[93],"should":[95],"characteristics":[97],"like":[98],"robustness,":[99,293],"eco-friendliness,":[100,294],"cost-effectiveness,":[101],"user-friendliness":[103],"following":[104],"recently":[106],"developed":[107,142,226],"idea":[108],"white":[110,135,268],"analytical":[111,136,194,269,276],"chemistry.":[112],"Teneligliptin":[113],"yet":[118],"simultaneously":[120],"estimated":[121],"using":[122,147,186],"a":[123,262],"method":[125,139,166,200],"has":[127,140],"documented":[129],"literature.":[132],"Methods":[133],"chemistry-assisted":[137],"RP-HPLC":[138,165,218,227,251],"fill":[144],"this":[145,265],"gap,":[146],"economical":[148],"eco-friendly":[150],"solvents.":[151],"design":[153,190,195,214],"experiment":[156],"approach":[157,291],"was":[158,197,232],"during":[160],"development":[162],"waste":[170],"guarantee":[172],"procedure":[175],"complied":[176],"all":[178],"applicable":[179],"regulations.":[180],"Response":[181],"surface":[182],"models":[183,272],"were":[184,244],"built":[185],"full":[188],"factorial":[189],"approach,":[191],"space":[196],"investigated.":[198],"This":[199],"allowed":[201],"identification":[204],"an":[206],"optimal":[207],"condition":[209],"within":[210],"method's":[212],"operational":[213],"region,":[215],"allowing":[216,281],"reliable":[217],"teneligliptin.":[223],"Results":[224],"underwent":[229],"validation":[230,253],"effectively":[234],"assess":[236],"drugs":[238],"their":[240],"fixed-dose":[241],"combinations.":[242],"Assessments":[243],"made":[245],"suggested":[248],"published":[250],"techniques'":[252],"status,":[254],"process":[255],"greenness,":[256],"cost,":[257],"time.":[260],"For":[261],"thorough":[263],"examination,":[264],"review":[266],"included":[267],"chemistry-based":[270,277],"RGB":[271],"different":[274],"green":[275],"tools.":[278],"Conclusion":[279],"In":[280],"simultaneous":[283],"estimate":[284],"pioglitazone,":[288],"devised":[290],"demonstrated":[292],"cost-effectiveness.":[296]},"counts_by_year":[{"year":2026,"cited_by_count":23},{"year":2025,"cited_by_count":21},{"year":2024,"cited_by_count":13}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2023-10-25T00:00:00"}